Breast cancer is the most common form of cancer among women in North America research hub

A phase III study comparing the concurrent versus the sequential administration of chemotherapy and aromatase inhibitors, as adjuvant treatment of post-menopausal patients with endocrine-responsive early breast cancer

This study is for women who have gone through menopause and have an early type of breast cancer that responds to hormones. Researchers are looking at the best way to give two important treatments: chemotherapy and hormone therapy. They want to see if giving them at the same time or one after the other is better.